New magnesium shield could save smiles after severe bone loss
NCT ID NCT07533110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special magnesium membrane (NOVAMag SHIELD) used with bone graft material to support immediate dental implants in people with severe bone defects after tooth extraction. The trial involves 40 adults who need a tooth removed in the front area and have significant bone loss. The goal is to see if this technique helps rebuild bone and supports long-term implant success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older; * Willingness and ability to provide informed consent and accept participation in the study. * Presence of a tooth indicated for extraction in the aesthetic zone (including premolars); * Clinical indication for immediate implant placement following tooth extraction; * Extraction sockets classified as Socket Type 3 (ST3), Subclass B or C, according to the Steigmann (2022) classification; Exclusion Criteria: * Pregnancy or lactating women; * Systemic diseases or conditions known to affect bone metabolism (osteoporosis, uncontrolled diabetes, metabolic bone disorders, chronic corticosteroid therapy, etc.); * Active infection at the surgical site, including the presence of an acute abscess or other signs of ongoing local infection; * Hypersensitivity to the biomaterials intended for use in the regenerative procedure.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alveolar buccal bone dehiscences are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinica Dentaria Egas Moniz
RECRUITINGAlmada, Setúbal District, 2829-511, Portugal